-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation